$108.33
2.742.59%
Last update: Nov 9, 4:10 PM
Zimmer Biomet Holdings Inc
ZBHNYSE
The average analyst price target for Zimmer Biomet Holdings is $111.82, 3.2% above the current price. Of 22 analysts, 10 rate it Buy and 12 Hold. Targets range from $86 to $140. The latest change came on Nov 9, 2026, when Barclays raised its price target on Zimmer Biomet Holdings from $100 to $115 and kept an Equal-Weight rating.
Price Target Range — 10 Quarters
Analyst Consensus — 22 Analysts
Rating Trend — Last 9 Months
